Lindis Blood Care GmbH

Lindis Blood Care Announces Positive Top-Line Results from Clinical Certification Study REMOVE with CATUVAB® to Enable Autologous Blood Transfusions in Cancer Surgeries

Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB® at NATA24 Annual Symposium

Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood

Lindis Blood Care Establishes Scientific Advisory Board of Leading Industry Experts

Lindis Blood Care successfully closes follow-on financing round

Lindis Blood Care Announces Publication of Clinical Pilot Study Results Successfully Highlighting the Potential of CATUVAB(R) in the Removal of Tumor Cells from Surgical Blood in Peer-Reviewed Journal

Lindis Blood Care Initiates Multicenter Clinical EU Certification Study REMOVE with CATUVAB(R) to Eliminate Tumor Cells from Surgical Blood